Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA556131
Max Phase: Preclinical
Molecular Formula: C14H23ClN2
Molecular Weight: 218.34
Molecule Type: Small molecule
Associated Items:
ID: ALA556131
Max Phase: Preclinical
Molecular Formula: C14H23ClN2
Molecular Weight: 218.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN1CCCC(c2cccc(N)c2)C1.Cl
Standard InChI: InChI=1S/C14H22N2.ClH/c1-2-8-16-9-4-6-13(11-16)12-5-3-7-14(15)10-12;/h3,5,7,10,13H,2,4,6,8-9,11,15H2,1H3;1H
Standard InChI Key: GWLUVEXOMYTFLE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 218.34 | Molecular Weight (Monoisotopic): 218.1783 | AlogP: 2.86 | #Rotatable Bonds: 3 |
Polar Surface Area: 29.26 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.79 | CX LogP: 2.59 | CX LogD: 0.23 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.79 | Np Likeness Score: -0.99 |
1. Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Sanchez D, Wikström H, Lindberg P, Hjorth S, Carlsson A.. (1981) 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity., 24 (12): [PMID:6796690] [10.1021/jm00144a021] |
Source(1):